BSX logo

Boston Scientific Corporation (BSX)

Profile

Full Name

Boston Scientific Corporation

Ticker

NYSE: BSX

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 19, 1992

Indexes

S&P 500

Website

https://www.bostonscientific.com

Employees

53000

Key Details

Price

$105.41(+0.47%)

Market cap

$155.95B(Mega cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$16.75B(+17.61% YoY)

Annual EPS

$1.25(+16.82% YoY)

PE ratio

62.74

Next earnings date

Oct 23, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $105.41
    BSX price is $105.41

    30-Day Relative Volume

    0.64
    BSX 30-day relative volume is 0.64

    Price Performance

    Price Most recent change

    +0.47%
    BSX price was up +0.47% on Aug 1, 2025

    Price YTD change

    +18.01%
    BSX price is up +18.01% since January 1st

    Price 1-year change

    +40.25%
    BSX price is up +40.25% year-on-year

    Price 3-year change

    +156.78%
    BSX price is up +156.78% over the past 3 years

    Price Range

    Price All-time high

    $108.94
    BSX price is currently -3.24% below its historical high of $108.94

    Price 3-year low

    $37.74
    BSX price is currently +179.31% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $155.95B
    BSX market capitalization is $155.95 billion

    Market cap 3-year change

    +165.36%
    BSX market capitalization is up +165.36% over the past 3 years

    Market cap All-time high

    $159.43B
    BSX market capitalization is currently -2.18% below its historical high of $159.43 billion

    Market cap sector rank

    99.01%
    BSX market capitalization is higher than 99.01% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.46%
    BSX shares outstanding is up +0.46% year-on-year

    Shares Outstanding 3-Year Change

    +3.34%
    BSX shares outstanding is up +3.34% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.72
    BSX beta is 0.72

    200-day SMA

    $97.93
    BSX price is currently +7.64% above its 200-day simple moving average

    50-day SMA

    $103.71
    BSX price is currently +1.64% above its 50-day simple moving average

    RSI

    53.06
    BSX 14-day relative strength index is 53.06

    Volume

    0.64
    BSX 30-day relative volume is 0.64

    ATR

    $2.03
    BSX average true range is $2.03

    10-day Historical Volatility

    26.83%
    BSX 10-day historical volatility is 26.83%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $16.75B
    BSX annual revenue is $16.75 billion

    Revenue Analysts estimate

    $19.84B
    BSX annual revenue is currently -15.60% lower than the consensus analysts' forecast

    Revenue 1-year change

    +17.61%
    BSX annual revenue is up +17.61% year-on-year

    Revenue Sector rank

    95.88%
    BSX annual revenue is higher than 95.88% of companies in Healthcare sector

    EPS

    EPS

    $1.25
    BSX annual earnings per share is $1.25

    EPS Analysts estimate

    $2.98
    BSX annual earnings per share is currently -58.09% lower than the consensus analysts' forecast

    EPS 1-year change

    +16.82%
    BSX annual earnings per share is up +16.82% year-on-year

    EPS Sector rank

    90.02%
    BSX annual earnings per share is higher than 90.02% of companies in Healthcare sector

    Profit

    Gross profit

    $11.46B
    BSX annual gross profit is $11.46 billion

    Gross margin

    68.41%
    BSX annual gross profit margin is 68.41%

    Operating profit

    $3.00B
    BSX annual operating income is $3.00 billion

    Operating margin

    17.93%
    BSX annual operating profit margin is 17.93%

    Net income

    $1.85B
    BSX annual net profit is $1.85 billion

    Net margin

    11.07%
    BSX annual net profit margin is 11.07%

    Expenses

    Total expenses

    $13.74B
    BSX annual total expenses is $13.74 billion

    Operating expenses

    $8.46B
    BSX annual total operating expenses is $8.46 billion

    Cost of goods sold

    $5.29B
    BSX annual cost of goods sold is $5.29 billion

    Selling, general & administrative expenses

    $5.98B
    BSX annual SGA is $5.98 billion

    Depreciation and amortization

    $1.27B
    BSX annual depreciation & amortization is $1.27 billion

    Interest expense

    $305.00M
    BSX annual interest expense is $305.00 million

    Income tax

    $436.00M
    BSX annual income tax is $436.00 million

    EBIT & EBITDA

    EBIT

    $2.59B
    BSX annual earnings before interest & taxes is $2.59 billion

    EBITDA

    $3.44B
    BSX annual EBITDA is $3.44 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $39.40B
    BSX annual total assets is $39.40 billion

    Non current assets

    $32.48B
    BSX annual long term assets is $32.48 billion

    Current assets

    $6.92B
    BSX annual total current assets is $6.92 billion

    Cash and cash equivalents

    $414.00M
    BSX annual cash & cash equivalents is $414.00 million

    Accounts receivable

    $2.56B
    BSX annual accounts receivable is $2.56 billion

    Inventory

    $2.81B
    BSX annual inventory is $2.81 billion

    Liabilities

    Total liabilities

    $17.39B
    BSX annual total liabilities is $17.39 billion

    Long term liabilities

    $10.99B
    BSX annual total long term liabilities is $10.99 billion

    Current liabilities

    $6.40B
    BSX annual total current liabilities is $6.40 billion

    Accounts payable

    $960.00M
    BSX annual accounts payable is $960.00 million

    Debt

    Total debt

    $11.15B
    BSX annual total debt is $11.15 billion

    Total debt 1-year change

    +17.44%
    BSX annual total debt is up +17.44% year-on-year

    Long term debt

    $9.37B
    BSX annual long term debt is $9.37 billion

    Short term debt

    $1.78B
    BSX annual short term debt is $1.78 billion

    Equity & Capital

    Shareholders equity

    $21.77B
    BSX annual stockholders equity is $21.77 billion

    Book value

    $21.77B
    BSX annual book value is $21.77 billion

    Retained earnings

    $2.67B
    BSX annual retained earnings is $2.67 billion

    Working capital

    $521.00M
    BSX annual working capital is $521.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $3.44B
    BSX annual cash flow from operations is $3.44 billion

    Cash from operations 1-year change

    +37.24%
    BSX annual cash flow from operations is up +37.24% year-on-year

    Cash from investing

    -$5.69B
    BSX annual cash flow from investing activities is -$5.69 billion

    Cash from investing 1-year change

    -120.94%
    BSX annual cash flow from investing activities is down -120.94% year-on-year

    Cash from financing

    $1.81B
    BSX annual cash flow from financing activities is $1.81 billion

    Cash from financing 1-year change

    +36180%
    BSX annual cash flow from financing activities is up +36180% year-on-year

    CAPEX

    CAPEX

    $1.07B
    BSX annual capital expenditures is $1.07 billion

    CAPEX 1-year change

    +33.75%
    BSX annual capital expenditures is up +33.75% year-on-year

    Free Cash Flow

    Free cash flow

    $2.37B
    BSX annual free cash flow is $2.37 billion

    Free cash flow 1-year change

    +38.87%
    BSX annual free cash flow is up +38.87% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    68.41%
    BSX annual gross profit margin is 68.41%

    Operating margin

    17.93%
    BSX annual operating profit margin is 17.93%

    Net margin

    11.07%
    BSX annual net profit margin is 11.07%

    ROA & ROE

    ROA

    4.98%
    BSX annual return on assets is 4.98%

    ROE

    8.93%
    BSX annual return on equity is 8.93%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    62.74
    BSX price to earnings ratio is 62.74

    PE ratio Sector rank

    88.07%
    BSX price to earnings ratio is higher than 88.07% of companies in Healthcare sector

    PB Ratio

    PB ratio

    -
    BSX price to book ratio value is unknown

    PB ratio Sector rank

    -
    BSX price to book ratio is unknown

    PS Ratio

    PS ratio

    8.43
    BSX price to sales ratio is 8.43

    PS ratio Sector rank

    75.2%
    BSX price to sales ratio is higher than 75.2% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -
    BSX enterprise value value is unknown

    Enterprise value Sector rank

    -
    BSX enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    BSX EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    BSX EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.08
    BSX annual current ratio is 1.08

    Quick ratio

    0.64
    BSX annual quick ratio is 0.64

    Leverage

    Debt to equity

    0.49
    BSX annual debt to equity ratio is 0.49

    Interest coverage ratio

    8.48
    BSX annual interest coverage ratio is 8.48

    Risk & Stability

    Piotroski F-Score

    -
    BSX piotroski f-score value is unknown

    Altman Z-Score

    6.13
    BSX altman z-score is 6.13

    Analyst ratings

    Recent major analysts updates

    Jul 24, 25 Wells Fargo
    Overweight
    Jul 24, 25 UBS
    Buy
    Jul 24, 25 Truist Securities
    Buy
    Jul 24, 25 Raymond James
    Strong Buy
    Jul 24, 25 Oppenheimer
    Perform
    Jul 24, 25 Barclays
    Overweight
    Jul 24, 25 Baird
    Outperform
    Jun 16, 25 Leerink Partners
    Outperform
    May 28, 25 Needham
    Buy
    May 22, 25 Citigroup
    Buy

    Institutional Ownership

    Screeners with BSX included

    Growing Shares Outstanding
    US stocks
    S&P 500 companies earnings calendar
    Most recommended stocks
    Best performing stocks last 5 years
    Stocks above SMA 50
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    • What is the ticker symbol for Boston Scientific Corporation?
    • Does Boston Scientific Corporation pay dividends?
    • What sector is Boston Scientific Corporation in?
    • What industry is Boston Scientific Corporation in?
    • What country is Boston Scientific Corporation based in?
    • When did Boston Scientific Corporation go public?
    • Is Boston Scientific Corporation in the S&P 500?
    • Is Boston Scientific Corporation in the NASDAQ 100?
    • Is Boston Scientific Corporation in the Dow Jones?
    • When was Boston Scientific Corporation's last earnings report?
    • When does Boston Scientific Corporation report earnings?

    What is the ticker symbol for Boston Scientific Corporation?

    The ticker symbol for Boston Scientific Corporation is NYSE:BSX

    Does Boston Scientific Corporation pay dividends?

    No, Boston Scientific Corporation does not pay dividends

    What sector is Boston Scientific Corporation in?

    Boston Scientific Corporation is in the Healthcare sector

    What industry is Boston Scientific Corporation in?

    Boston Scientific Corporation is in the Medical Devices industry

    What country is Boston Scientific Corporation based in?

    Boston Scientific Corporation is headquartered in United States

    When did Boston Scientific Corporation go public?

    Boston Scientific Corporation's initial public offering (IPO) was on May 19, 1992

    Is Boston Scientific Corporation in the S&P 500?

    Yes, Boston Scientific Corporation is included in the S&P 500 index

    Is Boston Scientific Corporation in the NASDAQ 100?

    No, Boston Scientific Corporation is not included in the NASDAQ 100 index

    Is Boston Scientific Corporation in the Dow Jones?

    No, Boston Scientific Corporation is not included in the Dow Jones index

    When was Boston Scientific Corporation's last earnings report?

    Boston Scientific Corporation's most recent earnings report was on July 23, 2025

    When does Boston Scientific Corporation report earnings?

    The next expected earnings date for Boston Scientific Corporation is October 23, 2025
    On this page